Lorcaserin: Making headway

Lorcaserin (Belviq)

INTRODUCTION In the U.S., obesity is prevalent in epidemic proportions, and rates continue to rise. Current data indicate that the combined prevalence of overweight and obese adults in the U.S. is 69.2%.1 The prevalence of obesity alone accounts for 35.7% of adults in the U.S., with men and women equally affected.2 In the U.S., approximately 18.4% of adolescents 12 to 19 years of age are obese....

Lorcaserin for weight management

Type 2 diabetes and obesity commonly occur together. Obesity contributes to insulin resistance, a main cause of type 2 diabetes. Modest weight loss reduces glucose, lipids, blood pressure, need for medications, and cardiovascular risk. A number of approaches can be used to achieve weight loss, including lifestyle modification, surgery, and medication. Lorcaserin, a novel antiobesity agent, affe...

Belviq, INN-Lorcaserin

Visual cues for manual control of headway

The ability to maintain appropriate gaps to objects in one's environment is important when navigating through a three-dimensional world. Previous research has shown that the visual angle subtended by a lead/approaching object and its rate of change are important variables for timing interceptions, collision avoidance, continuous regulation of braking, and manual control of headway. However, inv...

Head Development: Craniofacial genetics makes headway

Studies of neural crest migration in animal models, and of human syndromes in which craniofacial development is abnormal, are helping us to understand both prenatal and postnatal development of the head.